• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A life-threatening case of stenosing pill hypopharynx-oesophagitis caused by a tamsulosin capsule.

作者信息

D'Agostino L, Manguso F, Bennato R, Scaramuzzo A

机构信息

Department of Clinical and Experimental Medicine, Federico II University, Via S Pansini 5, 80131 Naples, Italy.

出版信息

Dig Liver Dis. 2004 Sep;36(9):632-4. doi: 10.1016/j.dld.2003.11.032.

DOI:10.1016/j.dld.2003.11.032
PMID:15460849
Abstract

Pill oesophagitis is a frequent clinical entity that may induce dysphagia and exceptionally oesophageal occlusion. The mechanisms inducing mucosal inflammation are not completely defined, but oesophageal damage occurring when the caustic content of a drug remains in the oesophagus long enough to produce mucosal lesions seems to be a main factor. We report a case of a life-threatening stenosing pill hypopharynx-oesophagitis caused by the ingestion of a capsule of tamsulosin, a drug diffusely used for benign prostatic hyperplasia treatment.

摘要

相似文献

1
A life-threatening case of stenosing pill hypopharynx-oesophagitis caused by a tamsulosin capsule.
Dig Liver Dis. 2004 Sep;36(9):632-4. doi: 10.1016/j.dld.2003.11.032.
2
Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study.α1受体阻滞剂治疗提示良性前列腺增生的下尿路症状患者所致射精功能障碍:那妥与坦索罗辛在一项随机多中心研究中的比较
Urol Int. 2009;83(1):49-54. doi: 10.1159/000224868. Epub 2009 Jul 27.
3
Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.两种剂量(10毫克和15毫克)的阿夫唑嗪或坦索罗辛(0.4毫克)每日一次治疗有症状的良性前列腺增生的疗效和安全性。
BJU Int. 2005 May;95(7):1006-12. doi: 10.1111/j.1464-410X.2005.05456.x.
4
The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia.多沙唑嗪标准制剂与胃肠道治疗系统治疗良性前列腺增生的临床疗效及耐受性
BJU Int. 2005 Mar;95(4):575-9. doi: 10.1111/j.1464-410X.2005.05342.x.
5
Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).对于有提示良性前列腺增生的下尿路症状(LUTS/BPH)的患者,从植物疗法改用坦索罗辛。
Prostate Cancer Prostatic Dis. 2005;8(3):210-4. doi: 10.1038/sj.pcan.4500803.
6
Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.坦索罗辛用于治疗良性前列腺增生导致急性尿潴留的患者。
BJU Int. 2005 Feb;95(3):354-7. doi: 10.1111/j.1464-410X.2005.05299.x.
7
Efficacy and safety of tamsulosin for benign prostatic hyperplasia: clinical experience in the primary care setting.
Curr Med Res Opin. 2006 Apr;22(4):721-30. doi: 10.1185/030079906X96443.
8
Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.新型α₁-肾上腺素能受体拮抗剂在治疗良性前列腺增生相关下尿路症状中的作用。
Clin Ther. 2004 Nov;26(11):1701-13. doi: 10.1016/j.clinthera.2004.11.006.
9
Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.两种α1肾上腺素能受体拮抗剂萘哌地尔和盐酸坦索罗辛治疗良性前列腺增生所致下尿路症状的比较:一项随机交叉研究。
BJU Int. 2006 Apr;97(4):747-51, discussion 751. doi: 10.1111/j.1464-410X.2006.06030.x.
10
Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia.
Int J Urol. 2004 Oct;11(10):870-5. doi: 10.1111/j.1442-2042.2004.00913.x.

引用本文的文献

1
Drug-induced esophageal injury with an occult vascular ring.隐匿性血管环所致药物性食管损伤
Paediatr Child Health. 2011 Nov;16(9):554-6. doi: 10.1093/pch/16.9.554.